# Fibromyalgia and Naltrexone: The FINAL Study

> **NCT04270877** · PHASE2 · COMPLETED · sponsor: **Odense University Hospital** · enrollment: 99 (actual)

## Conditions studied

- Fibromyalgia

## Interventions

- **DRUG:** Naltrexone Pill
- **DRUG:** Placebo oral tablet

## Key facts

- **NCT ID:** NCT04270877
- **Lead sponsor:** Odense University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-06
- **Primary completion:** 2022-12-27
- **Final completion:** 2022-12-27
- **Target enrollment:** 99 (ACTUAL)
- **Last updated:** 2022-12-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04270877

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04270877, "Fibromyalgia and Naltrexone: The FINAL Study". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04270877. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*